[1]
Liu, Y. et al. 2026. Immunomodulatory Effects of Hypomethylating Agents in Myelodysplastic Syndromes: Mechanisms and Therapeutic Implications. International Journal of Biology and Life Sciences. 14, 1 (Apr. 2026), 31–38. DOI:https://doi.org/10.54097/fqtz8e02.